$0.706
0.0344[5.12%]
At close: Apr 25
$0.706
0[0.00%]
After Hours: 7:22PM EDT
Cara Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cara Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/13/2024 | PM | CARA | Q1 | -$0.49 | — | — | — | $6.17M | — | — | — | Get Alert |
03/04/2024 | PM | CARA | Q4 | -$0.56 | -$0.41 | -$0.59 | -43.90% | $3.26M | $9.42M | $3.00M | -68.11% | Get Alert |
11/13/2023 | PM | CARA | Q3 | -$0.43 | -$0.52 | -$0.52 | 0.00% | $10.81M | $9.95M | $4.87M | -51.10% | Get Alert |
08/07/2023 | PM | CARA | Q2 | -$0.08 | -$0.56 | -$0.58 | -3.57% | $23.00M | $6.49M | $6.93M | 6.83% | Get Alert |
05/15/2023 | PM | CARA | Q1 | -$0.52 | -$0.52 | -$0.49 | 5.77% | $4.79M | $4.98M | $6.17M | 23.80% | Get Alert |
03/06/2023 | PM | CARA | Q4 | -$0.63 | -$0.32 | -$0.56 | -75.00% | $821.00K | $16.25M | $3.26M | -79.93% | Get Alert |
11/07/2022 | PM | CARA | Q3 | -$0.02 | -$0.42 | -$0.43 | -2.38% | $20.27M | $9.83M | $10.81M | 10.00% | Get Alert |
08/08/2022 | PM | CARA | Q2 | -$0.61 | -$0.25 | -$0.08 | 68.00% | $0.00 | $20.71M | $23.00M | 11.07% | Get Alert |
05/09/2022 | PM | CARA | Q1 | -$0.47 | -$0.54 | -$0.52 | 3.70% | $1.94M | $3.16M | $4.79M | 51.58% | Get Alert |
03/01/2022 | PM | CARA | Q4 | $1.59 | -$0.52 | -$0.63 | -21.15% | $112.09M | $1.46M | $821.00K | -43.77% | Get Alert |
11/08/2021 | PM | CARA | Q3 | -$0.35 | -$0.40 | -$0.02 | 95.00% | $9.27M | $11.21M | $20.27M | 80.84% | Get Alert |
08/09/2021 | PM | CARA | Q2 | -$0.54 | -$0.53 | -$0.61 | -15.09% | $5.63M | $2.36M | $0.00 | -100.00% | Get Alert |
05/10/2021 | PM | CARA | Q1 | -$0.62 | -$0.59 | -$0.47 | 20.34% | $8.09M | $2.36M | $1.94M | -18.01% | Get Alert |
02/25/2021 | PM | CARA | Q4 | -$0.61 | $0.36 | $1.59 | 341.67% | $4.51M | $48.63M | $112.09M | 130.49% | Get Alert |
11/09/2020 | PM | CARA | Q3 | -$0.74 | -$0.60 | -$0.35 | 41.67% | $5.79M | $4.77M | $9.27M | 94.26% | Get Alert |
08/10/2020 | PM | CARA | Q2 | -$0.58 | -$0.67 | -$0.54 | 19.40% | $5.21M | $5.06M | $5.63M | 11.34% | Get Alert |
05/11/2020 | PM | CARA | Q1 | -$0.56 | -$0.62 | -$0.62 | 0.00% | $4.38M | $4.76M | $8.09M | 70.02% | Get Alert |
02/27/2020 | PM | CARA | Q4 | -$0.52 | -$0.66 | -$0.61 | 7.58% | $5.53M | $4.79M | $4.51M | -5.82% | Get Alert |
11/05/2019 | PM | CARA | Q3 | -$0.51 | -$0.58 | -$0.74 | -27.59% | $5.06M | $4.34M | $5.79M | 33.29% | Get Alert |
Cara Therapeutics (CARA) is scheduled to report earnings on May 13, 2024. The last reported earnings were for reported on March 4, 2024 for Q4.
The Actual EPS was $-0.59, which missed the estimate of $-0.41.
The Actual Revenue was $3M, which missed the estimate of $9.4M.
Browse earnings estimates, EPS, and revenue on all stocks.